Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milnacipran for Neurocognition in Fibromyalgia
NCT01829243Phase 3Completed
- Sponsor
- Duke University
- Start
- Jul 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of milnacipran in fibromyalgia (FM), sponsored by Duke University. Started Jul 2011; status: completed.
02
Drugs
milnacipran
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT01829243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829243.